• 1. Unsymmetric salen ligands bearing a Lewis base: intramolecularly cooperative catalysis for cyanosilylation of aldehydes
  Ye-Qian Wen,Wei-Min Ren,Xiao-Bing Lu Org. Biomol. Chem. 2011 9 6323
• 2. Enantioselective trimethylsilylcyanation of some aldehydes catalysed by titanium alkoxide–chiral dialkyl tartrate complexes
  Masahiko Hayashi,Tohru Matsuda,Nobuki Oguni J. Chem. Soc. Perkin Trans. 1 1992 3135

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

Introduction to 2-hydroxy-2-(4-methoxyphenyl)acetonitrile (CAS No. 33646-40-1)

2-hydroxy-2-(4-methoxyphenyl)acetonitrile, identified by the Chemical Abstracts Service Number (CAS No.) 33646-40-1, is a significant intermediate in the field of organic synthesis and pharmaceutical chemistry. This compound, featuring a nitrile group and a hydroxyl-substituted aromatic ring, has garnered attention due to its versatile applications in the development of bioactive molecules. Its structural motif, combining a 4-methoxyphenyl group with a hydroxyacetonitrile core, makes it a valuable building block for synthesizing complex heterocyclic compounds and pharmacophores.

The 4-methoxyphenyl moiety, characterized by its electron-donating methoxy group attached to a benzene ring, enhances the reactivity of the aromatic system, facilitating various chemical transformations such as nucleophilic aromatic substitution and metal-catalyzed cross-coupling reactions. This feature is particularly useful in medicinal chemistry, where functionalization of aromatic rings is often required to optimize drug-like properties. The presence of the hydroxyacetonitrile group further contributes to the compound's utility, as it can undergo reduction to form alcohols or participate in condensation reactions to yield β-ketoesters or other nitrogen-containing derivatives.

In recent years, 2-hydroxy-2-(4-methoxyphenyl)acetonitrile has been explored in the synthesis of novel therapeutic agents. For instance, researchers have utilized this compound as a precursor in the preparation of small-molecule inhibitors targeting specific biological pathways. One notable area of interest is its application in developing kinase inhibitors, where the aromatic system and nitrile group can interact with protein active sites to modulate enzymatic activity. Preliminary studies have indicated that derivatives of this compound exhibit promising inhibitory effects on certain kinases, suggesting potential therapeutic applications in oncology and inflammatory diseases.

The pharmaceutical industry has also leveraged 2-hydroxy-2-(4-methoxyphenyl)acetonitrile in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs). The hydroxyl and nitrile functionalities provide opportunities for further derivatization, allowing chemists to fine-tune physicochemical properties such as solubility, lipophilicity, and metabolic stability. By modifying the substituents around the benzene ring or introducing additional functional groups, researchers can enhance the pharmacological profile of NSAID analogs derived from this intermediate.

Moreover, advancements in green chemistry have prompted investigations into sustainable synthetic routes for 2-hydroxy-2-(4-methoxyphenyl)acetonitrile. Catalytic methods employing transition metals have been optimized to improve yields and minimize waste. For example, palladium-catalyzed cross-coupling reactions have enabled efficient construction of the 4-methoxyphenyl moiety without excessive byproduct formation. Such innovations align with global efforts to reduce the environmental footprint of chemical manufacturing while maintaining high standards of product purity and performance.

The role of computational chemistry in designing derivatives of 2-hydroxy-2-(4-methoxyphenyl)acetonitrile cannot be overstated. Molecular modeling techniques have been instrumental in predicting binding affinities and optimizing molecular architectures for enhanced biological activity. By integrating experimental data with theoretical calculations, scientists can accelerate the discovery process and identify lead compounds with improved efficacy and reduced toxicity. This interdisciplinary approach underscores the importance of collaboration between experimentalists and computational chemists in advancing drug discovery initiatives.

In conclusion, 2-hydroxy-2-(4-methoxyphenyl)acetonitrile (CAS No. 33646-40-1) represents a versatile intermediate with broad applications in pharmaceutical research and industrial synthesis. Its unique structural features enable diverse chemical modifications, making it a valuable asset for developing novel bioactive molecules. As research continues to uncover new synthetic strategies and pharmacological applications, this compound is poised to remain a cornerstone of modern medicinal chemistry.

• 39515-47-4(a-Hydroxy-3-phenoxybenzeneacetonitrile (>90%))
• 61826-76-4((S)-2-Hydroxy-2-(3-phenoxyphenyl)acetonitrile)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)